Parkinson's Disease (PD) is a complex and heterogeneous neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta and pathological intracellular accumulation of alpha-synuclein (α-syn). In the vast majority of PD patients, the disease has a complex etiology, defined by multiple genetic and environmental risk factors. Common genetic variants in the human leukocyte-antigen (HLA) region have been associated to PD risk and the carriage of these can double the risk to develop PD. Among these common genetic variants are the ones that modulate the expression of MHCII genes. MHCII molecules encoded in the HLA-region are responsible for antigen presentation to the adaptive immune system and have a key role in inflammatory processes. In addition to cis variants affecting MHCII expression, a transactivator encoded by the Mhc2ta gene is the major regulator of MHCII expression. We have previously identified variations in the promoter region of Mhc2ta, encoded in the VRA4 region, to regulate MHCII expression in rats. The expression of MHCII is known to be required in the response to α-syn. However, how the expression of MHCII affects the activation of microglial or the impact of physiological, differential Mhc2ta expression on degeneration of dopaminergic neurons has not previously been addressed. Here we addressed the implications of common genetic allelic variants of the major regulator of MHCII expression on α-syn-induced microglia activation and the severity of the dopaminergic neurodegeneration. We used a viral vector technology to overexpress α-syn in two rat strains; Dark agouti (DA) wild type and DA.VRA4-congenic rats. The congenic strain carries PVG alleles in the VRA4 locus and therefore displays lower Mhc2ta expression levels compared to DA rats. We analyzed the impact of this physiological differential Mhc2ta expression on gliosis, inflammation, degeneration of the nigro-striatal dopamine system and behavioral deficits after α-syn overexpression. We report that allelic variants of Mhc2ta differently modified the microglial activation in response to overexpression of human α-syn in rats. Overexpression of α-syn led to a larger denervation of the nigro-striatal system and significant behavioral deficits in DA.VRA4 congenic rats with lower Mhc2ta expression compared to DA rats. These results indicate that Mhc2ta is a key upstream regulator of the inflammatory response in PD pathology.
Introduction
Parkinson's Disease (PD) is a complex and heterogeneous neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) that innervate the striatum and pathologic accumulation of alpha-synuclein (α-syn) protein in Lewy bodies and Lewy neurites (Clark et al., 2007; Spillantini et al., 1998) . Mutations in genes encoding glucocerebrosidades (GBA) (Clark et al., 2007) , parkin (PARK2) (Djarmati et al., 2004) , PTEN-induced putative kinase 1 (PINK1) (Bonifati et al., 2005) , DJ1(PARK7) (Djarmati et al., 2004) , leucine-rich repeat kinase 2 (LRRK2) (Zimprich et al., 2004) , and α-syn (SNCA) (Polymeropoulos et al., 1997) have been causative associated to PD. However, b10% of the cases can be characterized as monogenic (Ross, 2013) . The remaining 90% of the cases present a complex and multifactorial etiology, where a probable interaction between environmental and genetic factors initiates the selective degeneration of dopaminergic neurons in the SNpc and the development of PD pathology. In the quest to understand the etiology of PD, a recent GWAS meta-analysis identified 28 genetic risk loci for PD (Nalls et al., 2014) .
α-Syn has a central and well-established role in PD, both pathologically as a hallmark in Lewy bodies and Lewy neurites (Spillantini et al., 1998) , and genetically. SNCA is one of the risk loci identified for idiopathic PD (Nalls et al., 2014) and SNCA mutations or copy number variations cause monogenic PD (Chartier-Harlin et al., 2004; Ibanez et al., 2004; Polymeropoulos et al., 1997) . It is thus relevant to note that α-syn plays a critical role in individuals with both idiopathic and monogenic forms of PD and can be used to model PD. The overexpression of human wild type α-syn in rodent and primates leads to progressive pathology with axonal abnormalities, loss of dopaminergic neurons, and behavioral impairment (Decressac et al., 2012; Eslamboli et al., 2007; Kirik et al., 2003) . In addition, α-syn overexpression leads to microglial activation even in the absence of cell death, suggesting that microglia play a role early-on in the process of α-syn induced neurodegeneration (SanchezGuajardo et al., 2010) . Several studies have reported that microglial activation in vivo correlates with fibrillar α-syn deposition in post-mortem human SNpc affected by idiopathic PD (Croisier et al., 2005) and α-syn per-se is capable of activating rodent microglia in vitro (Zhang et al., 2005) .
It has long been known that antigen-presenting MHCII molecules are up-regulated on microglia in the brains of Alzheimer's and PD patients (McGeer et al., 1988) . Recent studies report progressive changes in morphology of MHCII-expressing microglia in neurodegenerative diseases (Walker and Lue, 2015) and morphological similarities between human and rodent microglia suggest highly conserved functions between species (Torres-Platas et al., 2014) . Microglial activation is currently seen as a plastic multifaceted response, finely tuned by: i) the nature of the stimulus, ii) the molecular repertoire that is engaged, and iii) the prior state of the cell (Gomez-Nicola and Perry, 2015) . Whether activation of microglia plays a beneficial or detrimental role in PD remains controversial (Al Nimer et al., 2011; Sanchez-Guajardo et al., 2013) . However, genetic and experimental studies point out antigen presentation capacity as a factor in PD pathogenesis. Several variants in the Human Leukocyte Antigen (HLA) locus encoding MHCII molecules are associated to PD and can double disease risk (Hamza et al., 2010) . Risk HLA-variants have been suggested to cause a shift towards a proinflammatory response to certain environmental challenges (Kannarkat et al., 2015) . It has also recently been shown that mice lacking MHCII lack α-syn-induced microglial activation and are protected from dopaminergic neurodegeneration (Harms et al., 2013) . These results suggest antigen presentation capacity through MHCII as a contributing causative factor in PD.
The VRA4 locus on rat chromosome 10 is linked to MHCII expression after nerve injury (Harnesk et al., 2008; Lidman et al., 2003) and modulates the response to experimental autoimmune encephalomyelitis (Harnesk et al., 2008; Lidman et al., 2003) and traumatic brain injury (Al Nimer et al., 2011) . We and colleagues fine-mapped the VRA4 locus to a polymorphism in the promoter of the MHCII transactivator (Mhc2ta) (Swanberg et al., 2005) , encoding the master regulator of MHCII transcription (Chang and Flavell, 1995) . Allelic differences in the rat Mhc2ta promoter lead to differential expression levels of CIITA protein and, as a secondary effect, MHCII molecules in the CNS and on peripheral immune cells (Harnesk et al., 2008; Swanberg et al., 2005) . Of note, corresponding promoter polymorphisms were found to regulate MHC2TA and MHCII expression in humans, and to affect the susceptibility to human neuroinflammatory disease (Swanberg et al., 2005) . It has, however, not previously been studied if VRA4 modulates microglial activation or outcome in PD-like pathology.
To study the effects of allelic differences in Mhc2ta on α-syn toxicity and microglial response in vivo we compare the DA.VRA4 congenic strain, carrying PVG av1 alleles in the VRA4-locus on a DA strain background (Harnesk et al., 2008) , with the parental DA strain in an α-syn overexpression model. Here, we show for the first time that differential expression of Mhc2ta leads to a distinctive activation of microglia and modifies dopaminergic neurodegeneration induced by α-syn overexpression.
Experimental procedures

Animals
The DA-PVG av1 -VRA4 (DA.VRA4) congenic strain was developed by transferring VRA4-locus alleles from PVG av1 to the DA background strain (Harnesk et al., 2008) (Fig. 1A) . Adult male rats (n = 8 per group) were housed two to three per cage with ad libitum access to food and water during a 12 h light/dark cycle. All procedures were conducted in accordance with guidelines set by the Ethical Committee for the use of laboratory animals in the region Lund-Malmö (M188-14).
Viral vectors
Two different recombinant adeno-associated viral (rAAV6) vectors constructs were used to overexpress either GFP or human wild-type α-syn in the midbrain of the experimental animals. The expression of the transgene is guided by the synpasin-1 promoter and enhanced using a woodchuck hepatitis virus posttranscriptional regulatory element (Decressac et al., 2012) . The final titers of the concentrated vector stocks were as follows: rAAV6-GFP (9,6E+14 gc/ml) and rAAV6-α-syn (3,6E+14 gc/ml), as determined by ITR-qPCR. Ten percent dilutions of the batches were adjusted so that a comparable number of genome copies were injected across experimental groups.
Experimental design
The present study was conducted in two parts, a behavioral experiment and a follow-up study for gene expression analysis. For the first part we used 20 weeks-old DA and DA.VRA4 congenic rats divided into two groups (rAAV6-α-syn, and rAAV6-GFP, n = 8 per group). Rats received either 3 μl of rAAV6-GFP or rAAV6-α-syn. Motor behavior was assessed at 3, 8 and 12 weeks post-injection. To determine the severity of dopaminergic degeneration animals from both groups were euthanized at 12-weeks post-injection. Immunohistochemical analyses of the striatum and SN were conducted on both groups. In a follow-up study, 20 weeks-old DA and congenic DA.VRA4 rats (n = 8 per group) received 3 μl of rAAV6-α-syn and were euthanized 8 weeks post-injection. Animals were used to determine the levels of gene expression of different inflammatory markers.
Genotyping
Genomic DNA was extracted from tail tips using a standard protocol. High Resolution Melt (HRM) analysis was conducted to determine the genotype, using a CFX96 system (CFX96tm Real-Time System, Bio-Rad Laboratories, US). Two markers where selected, from a previous study (Harnesk et al., 2008) one inside the congenic region and one in the non-congenic region. DNA from DA and PVGav1 parental rats were included for each marker as a control.
Vector delivery
Intranigral injections were performed under 1-2% isoflourane anesthesia (Isoflo vert, Orion Pharma AB Animal Health, Sweden) in a 2:1 O 2 :NO mixture. In brief, rats were placed in a stereotaxic frame (Kopf Instruments) and the vector solution was injected using a 10 μl Hamilton syringe fitted with a glass capillary (Soelting, #50811). 3 μl of rAAV6-GFP (9.6E+10 gc/μl) or rAAV6-α-syn (3.6E+10 gc/μl) were delivered into the SN at the following coordinates (flat skull position): AP: − 5.3 mm, ML: − 1.7 mm, and DV: − 7.2 mm, below dural surface as calculated relative to bregma (Paxinos and Watson, 2007) . After each injection the needle was left in place for an additional 2 min to allow for diffusion of the vector.
Behavioral test
Two different assessments of behavior were performed at 3, 8, and 12 weeks after vector injection in the SN. Both behavioral tests were performed by the same experimenter, blinded to the group-identity throughout the study, in the same testing room, and at the same interval during the day (9-12 AM).
Stepping test
Forelimb akinesia was assessed performing the stepping test (Olsson et al., 1995) . Briefly, the researcher moved the rat horizontally over a fixed distance (90 cm) for 3 trials. Steps for each forelimb were recorded and averaged across trials. Data are presented as the average number of adjusting steps made by the contralateral forepaw within groups.
Cylinder test
Forelimb asymmetry was assessed performing the cylinder test (Alvarez-Fischer et al., 2008; Schallert et al., 2000) . In this test the paw movements during natural exploratory behavior were scored. Rats were placed in a glass cylinder, with 2 mirrors placed at an angle of 90°behind to allow for assessment of the subject from all angles. Spontaneous use of the forepaws was video-recorded and analyzed post-hoc. The first 20 touches made were counted. Data are presented as the average number of left paw touches (contralateral to the injection) by the number of right paws touches (ipsilateral to the site of injection) within groups.
Perfusion and tissue processing
Twelve weeks after intranigral injection animals were sacrificed under anesthesia with 0.2 ml sodium pentobarbital i.p. (40 mg/kg) (Apotek Production & Laboratories AB, Sweden) and then transcardially perfused with 0.9% saline followed by ice-cold paraformaldehyde (PFA; 4%, pH 7.4). The brains were collected and post-fixed in 4% PFA overnight and then cryoprotected in 30% sucrose (in PBS, with 0.01% sodium azide) until sunk. The brains were sectioned on a freezing sledge microtome (MICROM, HM450, Thermo Scientific TM, US) and coronal sections were collected in a 1:12 series at a thickness of 35 μm. For gene expression experiments, animals were deeply anesthetized and sacrificed at 8 weeks after rAAV6 injection, the brain was isolated and midbrain and striatum obtained after micro dissection and storage at −80°C for further analysis.
Immunohistochemistry
Immunohistochemical stainings were performed on free-floating sections as described in (Kurowska et al., 2016) . Using primary antibodies raised against tyrosine hydroxylase (TH) (mouse, #22941, ImmunoStar Inc., US, 1:1000), human α-syn (#sc-12,767, Santa Cruz, US, 1:10,000), GFP (chicken, #ab13970, Abcam, 1:20,000), MHCII (mouse, OX-6, #ab23990, Abcam, 1:250), CD68 (mouse, ED1, #MCA3416A, AbD Serotec, 1:200), CD11b (mouse, Mac1, #MCA275GA, Bio-Rad, 1:500). In brief, sections were rinsed (3×) in phosphate buffer (PBS) between each incubation step. All incubation solutions contained 0.25% Triton X-100 in PBS. Antigen-retrieval incubation was performed, in Tris/EDTA (pH 9.0) at 80°C for 45 min on the sections stained with TH. To reduce endogenous peroxidase activity the sections were quenched in 3% H 2 O 2 /10% Methanol in PBS. After one hour of incubation in 5% blocking solution (serum against the species of secondary antibody) the sections were incubated in the respective primary antibody overnight. Following washes in PBS-T, the sections were incubated with the corresponding biotinylated secondary antibody (1:200, Vector laboratories) for 1 h at room temperature. Following a washing step, sections were incubated in an avidinbiotin peroxidase solution for 30 min (ABC Elite, Vector laboratories). The antigen was visualized using 3,3-diaminobenzidine (DAB) as a chromogen. The sections stained with CD11b, CD68, MHCII, were counterstained with cresyl violet (0.5% solution). Sections were mounted on glass slides, dehydrated with increasing concentrations of ethanol and pure xylene, and finally coverslipped using DPX mounting medium (Sigma-Aldrich, Gillingham). Sections with uneven, blurry, not penetrating staining were excluded from analyses.
Densitometry analysis
Striatal TH + fiber density was measured by densitometry at four coronal levels (1.60, 0.48, − 0.26, and −0.40 mm, relative to bregma) using the ImageJ software (Version 1.49, NIH, USA). The photographs were obtained using a Light microscope (Olympus BX53). Each image was analyzed using the optical density values obtained from the calibrated step after being transformed into 8-bit image. The measures were normalized by measuring and subtracting background staining optical density from the corpus callosum for each animal. The data are presented as percentage of contralateral side density.
Stereological estimates of nigral neurons
Unbiased stereological estimations of the total number of TH+ cells in the SN were performed according to the optical fractionator principle (West and Gundersen, 1990) as described previously (Kurowska et al., 
2016
). An observer blinded to the identity of the animal performed the counts employing MicroBrightfield stereological investigator software (StereoInvestigator, MBF Bioscience, V10, US) under 100× magnification using a Leica microscope connected to digital camera (Leica MPS52). Every sixth section (section sampling fraction, ssf = 6) of the midbrain region (Bregma − 2.70 to − 3.78) (Paxinos and Watson, 2007) which yielded between 8 and 10 sections per animal. Tracing regions of interest (ROIs) was done using a 5 ×/0.11 lens, and counting was performed with a 100 ×/1.30 lens. The average mounted section thickness (h) was 23,8(±3.9) and no guard zones were used due to variable in section thickness (thickness sampling fraction, tsf = 1). Section thickness was measured at every fourth site while counting and the area-sampling fraction (asf) was on average. Dissector volume (h * A frame) was 10,9760 mm 3 on average, and the average number of dopaminergic neurons counted in each individual was 116,0 (±34). A maximal Gundersen coefficient of error (CE) 52 of 0.08 was accepted, and the smoothness factor (m) of 1 was used. The counting frame was placed randomly by the stereoinvestigator software and moved systematically until the entire delineated region was sampled. 5 of 8 GFP DA and 4 of 8 GFP DA.VRA4were excluded from the analysis due to complications with tissue processing.
Stereological estimates and morphological characterization of microglia
For microglia quantification a protocol described before was used (Sanchez-Guajardo et al., 2010) . In brief, for the SN cells, every sixth section from the entire SN (8 sections per animal) was stained and counted. For quantifications in the Striatum, every sixth section from the entire striatum (8 sections per animal) from to the −1.80 relative to bregma, were used. Four distinct cells profiles were analyzed: Type A, cells with no visible cytoplasm, a round dense nucleus, and with long thin processes with little branching; Type B, cells with a visible thin cytoplasm surrounding a dense nucleus; processes are very long and thin, with many branches of less defined edges; Type C, cells with elongated and irregular body, enlarged and less defined nucleus, and with shorter re-defined processes of varying thickness and little branching. Type D, have big cell body merging with the processes, the nucleus occupies most of the cell body and is not always distinguishable; processes are few thick and short (indistinguishable from peripheral macrophages). The counting frame was defined by the probe which was used to count the neurons in SNpc sections (West et al., 1991) . It was defined as 56 × 56 for SN and 53 × 53 in ST in this project. Within the counting frame, the optical fractionator estimated the total number of Mac1 + cells from the number of cells counted with systemic randomly samples (SRS) set of unbiased counting spaces covering the selected counting frame in the region of interest (Mouton, 2002) . The SRS layout was standardized to 211 × 211 in this experiment. The threshold for coefficient of error for each animal was set at 0.06.
Immunohistochemical analysis and quantification of immune markers
For MHCII +, 3-4 equally distant sections of the SN and striatum from each animal were selected and the quantifications were made using a bright-field Leica DMI600B microscope at a magnification of 10 ×. Positive cells close to the site of injection or needle track were discarded to analyze just the response to α-syn and not the response due to the tissue damage caused by insertion of capillary used for rAAV6-injection. In the striatum we counted cells within the entire structure.
RT-PCR
At 8 weeks after injection animals were sedated by intraperitoneal injection of 0.2 ml sodium pentobarbital (40 mg/kg). Midbrain and striatum were dissected coronally using a rat brain slice matrix and ipsilateral and contralateral side were obtained through a sagittal cut. Samples were kept at − 80°C. Total RNA was extracted from DA and DA.VRA4 animals using the miRNeasy kit (Qiagen, USA) according to the manufacturer's instructions. Samples of total RNA (100 ng) were reverse-transcribed using SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen, USA) using oligo-DT primer to generate cDNA. Real-time PCR was conducted using SYBR Green according to manufacturer's instructions (Applied Biosystems) with specific primers (Table 1) . Using a GENORM analysis β-actin and GAPDH were use as reference genes, and relative expression levels were determined according to the ΔΔCt method. Data are presented as fold change compared to the control or contralateral side.
Statistical analysis
Data are expressed as mean ± standard error of the mean (SEM) and analyzed with the GraphPad Prism (GraphPad software package INC., San Diego, CA, USA, version 5). Groups were compared using analyses of variance (ANOVA) and post hoc Bonferroni test correction for multiple comparisons. P-and F values are given in the figure legends, while post-hoc pairwise comparisons are reported, in both Results and figure legends, as being either significant or non-significant. To analyze any direction of the effect unpaired t-test student two-tailed was used where appropriate (see legend figures). A significance level of α = 0.05 was chosen for all analyses.
Results
Transgene-induced α-syn expression and pathology following rAAVvector delivery
To examine the effect of Mhc2ta expression levels in response to α-syn overexpression in vivo, 20-weeks-old male DA and DA.VRA4 congenic rats (Fig. 1A) received a unilateral stereotactic injection of rAAV6-α-syn or rAAV6-GFP virus into the right SNpc. Twelve weeks post-transduction, strong protein expression of α-syn (Fig. 1B and C) or GFP (data not shown) was observed throughout the ipsilateral nigro-striatal system. Pathological swellings and dystrophic axonal structures, characteristic of axonopathy, were observed in the striatum of animals overexpressing α-syn (Fig. 1B) .
DA.VRA4 rats display increased number of antigen presenting cells after α-syn overexpression
To determine whether the Mhc2ta expression levels affect the antigen presenting cells response to α-syn, we performed semi-quantitative analysis of MHCII + cells in the ipsilateral vs contralateral striatum and SN of DA and DA.VRA4 congenic rats 12 weeks post unilateral rAAV6 injection. MHCII+ cells were preferentially grouped in the dorsal striatum and along the border of corpus callosum in both rat strains receiving rAAV6-α-syn or rAAV6-GFP vectors ( Fig. 2A-D) . Overexpression of GFP did not induce any significant change in the number Table 1 Primers used for semi quantitative real-time polymerase chain reaction.
Gene
Forward primer Reverse primer
of MHCII + cells on the ipsilateral compared to the contralateral striatum in DA or DA.VRA4 rats (Fig. 2E) , with a similar fold increase in both strains (Fig. 2F) . On the contrary, when α-syn was overexpressed, there was a significant increase in the number of MHCII + cells in the ipsilateral striatum of both DA and DA.VRA4 rats (Fig. 2E) . The fold increase in MHCII + cell was significantly higher in DA.VRA4 rats (1.969 ± 0,171) compared to DA (1.406 ± 0,131, p b 0.05, Fig. 2G ). The increase in MHCII + cells in DA.VRA4 ipsilateral striatum was specific to α-syn overexpression, since the ratio of MHCII+ cells in the ipsilateral vs. contralateral striatum was significantly higher in DA.VRA4 rats overexpressing α-syn (1.969 ± 0,171) compared to GFP (1.161 ± 0,078, p b 0.01).
In the SN, where the viral vector was injected, the number of MHCII + cells was significantly increased in the ipsilateral side of DA, but not DA.VRA4 rats overexpressing GFP (Fig. 2L) . However, the overexpression of α-syn induced a significant increase in the number of MHCII + cells in the ipsilateral SN of both DA and DA.VRA4 rats (Fig. 2L) . There was a similar trend in the SN as in the striatum with increased ratio of MHCII+ cells in the ipsilateral vs. contralateral side (Fig. 2N) . 3.3. DA.VRA4 rats express lower levels of Mhc2ta after α-syn overexpression The expression levels of Mhc2ta and MHCII transcripts were determined by RT-PCR in the contra-and ipsilateral striatum and midbrain of DA and DA.VRA4 rats at 8 weeks after rAAV6-α-syn injection in SN. When relating expression levels relative to two housekeeping genes Gapdh and β-actin, the levels of Mhc2ta were lower in the ipsilateral striatum and midbrain of DA.VRA4 compared to DA rats, while MHCII expression was only lower in the contralateral midbrain of DA.VRA4 rats compared to DA (Fig. S1) .
Since Mhc2ta and MHCII are primarily expressed by microglia in the brain, we next determined the expression of Mhc2ta and MHCII relative to the microglial marker Iba1 (Fig. 3) . DA.VRA4 displayed significantly lower expression of both Mhc2ta and MHCII compared to DA rats in the ipsilateral striatum (Fig. 3F, J) and midbrain (Fig. 3H, L) . The expression levels of Mhc2ta and MHCII in individual striatal samples are strongly correlated (r = 0.49, p b 0.01). These results show that allelic differences in Mhc2ta regulate the expression levels of both Mhc2ta and MHCII, which are expressed primarily in microglia, when α-syn is overexpressed in vivo.
DA.VRA4 rats display more activated microglia after α-syn-overexpression
Upon activating signals, microglia change morphology by increasing their ramifications and cell body size. To analyze whether the allelic difference in Mhc2ta have an effect on the quantity and profile of microglia, stereological quantification of Cd11b+ (Mac1+) cells and morphological profiling were performed in the striatum and SNpc of DA and DA.VRA4 rats 12 weeks after rAAV-α-syn or rAAV-GFP unilateral injection to the SN.
In the striatum, no significant differences in the number of Cd11b+ cells were observed when comparing sides (ipsilateral vs. contralateral), strains (DA vs. DA.VRA4) or transgenes (GFP vs. α-syn, Fig. 4A ). In the SN, however, DA.VRA4 displayed a significant increase in the total animals. E-K Real-time qRT-PCR comparing the effects of VRA4-allelic difference on total expression of Mhc2ta and MHCII related to the expression levels of Iba1 in the striatum and midbrain of DA and DA.VRA4 animals. F. Ipsilateral Mhc2ta expression levels are significantly lower in the striatum of DA.VRA4 animals and H. midbrain relative to DA. I, J and L. MHCII expression was lower in DA.VRA4 rats compared to DA. Gene expression was log2 transformed using Iba1 expression levels as reference and data shown are normalized to contralateral DA levels. Fold change (ΔΔCT) (mean ± SEM, n = 8) shown. Unpaired t-test two-tailed was performed between groups, *p b 0.05. **p b 0.01. ***p b 0.001. number of Cd11b+ microglia in the ipsilateral vs. contralateral SN for both transgenes (Fig. 4A) .
We next analyzed the relative number of four different microglial profiles (Fig. 4B) as previously described (Sanchez-Guajardo et al., 2010) . Normally the rat brain microglia present mostly a resting (type A), or a hyper-ramified profile (type B). Rare hypertrophic-bushy (type C) microglia are observed in a healthy brain, while amoeboid (type D) microglia are rare (Sanchez-Guajardo, 2010).
The proportion of Type A microglia in the striatum was significantly lower in the ipsilateral side of animals overexpressing α-syn compared to GFP (DA 42.9% vs. 54.8%, p b 0.01, DA.VRA4 32.7% vs. 57.3%, p b 0.001, Fig. 4C ). Instead there was an increase in the proportion of hyperamified (Type B) microglia in both strains overexpressing α-syn compared to GFP (DA 48.5% vs. 41.6%, p b 0.05, DA.VRA4 53.9% vs. 40.3%, p b 0.05). Hypertrophic (Type C) microglia represented b4% of the microglia in both strains when overexpressing GFP, but in animals overexpressing α-syn represented 7.2% in DA (n.s.) and 11.7% in DA.VRA4 rats (p b 0.05). This proportion of Type C microglia in the striatum of rats overexpressing α-syn was significantly higher in DA.VRA4 vs DA rats (p b 0.001, Fig. 4C ). Type D microglia were only observed in the ipsilateral side of animals expressing α-syn, with no significant difference between DA and DA.VRA4 animals (DA 1.4%, DA.VRA4 2.7%).
Also in the ipsilateral SN, there was a lower proportion of Type A microglia in rats overexpressing α-syn compared to GFP (DA 52.7% vs. 66.6%, n.s., DA.VRA4 40.3% vs. 67.5%, p b 0.0001), and the proportion was significantly lower in DA.VRA4 compared to DA (p b 0.001, Fig. 3D ). The reduction in the percentage of Type A microglia was accompanied by an increment in the hyper-ramified (Type B) microglia (DA 41.1% vs. 31.8%, n.s., VRA4 50.3% vs. 31.4%, p b 0.01). Hypertrophic microglia (Type C) represented b 2% in animals overexpressing GFP with a non-significant increase in animals overexpressing α-syn (DA 4.6%, DA.VRA4 6.8%). As in the striatum, Type D microglia were only observed in the ipsilateral SN of animals expressing α-syn, with no significant difference between DA compared to DA.VRA4 animals (DA 1.7%, DA.VRA4 2.6%).
The amount of phagocytic cells in the striatum was estimated by CD68+ stainings showing an increase in the number of CD68+ cells in ipsilateral vs. contralateral striatum of both DA and DA.VRA4 rats overexpressing α-syn but not GFP. However, there was no difference in number of CD68+ cells between the two strains (data not shown). Thus, DA.VRA4 rats, with a lower transcriptional activity of Mhc2ta and MHCII, display a microglial population with a more activated profile in response to α-syn compared to DA.
DA.VRA4 rats present altered inflammatory profile
To address whether differential levels of Mhc2ta and MHCII have an effect on the inflammatory response after α-syn-overexpression, the mRNA expression levels of CD74 (MHCII antigen gamma chain, involved in the formation and transport of MHCII (Vyas et al., 2008) ), CD86 (costimulatory signal for T-cell activation (Pentcheva-Hoang et al., 2004) ) or Arg-1 (anti-inflammatory enzyme regulated by STAT6 (Munder et al., 1999) ) were determined in the striatum and midbrain of DA and DA.VRA4 rats 8 weeks post rAAV-α-syn injection.
In the striatum, no differences were observed in the levels of Cd74, Cd86 or Arg-1 between DA and DA.VRA4 rats (Fig. 5A-F) . In the midbrain, the relative gene expression in the ipsilateral side was significantly lower in DA.VRA4 compared to DA rats for Cd74 (Fig. 5H, p b 0.05) and Arg-1 (Fig. 5L, p b 0.05) .
Quantitative differences in specific cell populations between the studied strains will impact on gene expression data from homogenized tissue when related to ubiquitous housekeeping genes. We therefore also analyzed gene expression related to a microglial/macrophage specific housekeeping gene, Iba1 (Fig. S2) . The profile was similar to that obtained with Gapdh/β-actin as reference genes, with DA.VRA4 rats displaying a reduced antigen-presenting capacity (CD74 and CD86 expression) and reduced Arg-1 expression in the ipsilateral side.
These results indicate that upon α-syn overexpression, microglia in the DA.VRA4 congenic strains have a reduced antigen-presenting capacity and less anti-inflammatory profile compared to DA rats.
DA.VRA4 rats show exacerbated α-syn pathology
To evaluate the impact of MHCII on α-syn-induced pathology, striatal axonal projections of nigral dopaminergic neurons were evaluated by stainings for TH. Immunohistochemical analysis showed dense TH-stained (TH+) fibers throughout the striatum of DA and DA.VRA4, not affected by GFP overexpression (Fig. 6A-B) . However, α-syn overexpression led to a significant loss of TH fiber staining intensity in the ipsilateral striatum of DA.VRA4 rats but not in DA rats (Fig. 6C-D) . The TH + fiber staining intensity in the dorsal striatum of DA.VRA4 rats overexpressing α-syn was reduced by around 30% compared to GFP (p b 0.001) and reduced by 20% compared to DA rats overexpressing α-syn (p b 0.05, Fig. 6E ).
Stereological quantification of TH+ neurons in SNpc did not reveal any significant differences between strains or transgenes ( Fig. 5A′-D′) . However, a trend in reduction of TH + neurons was observed in DA.VRA4 compared to DA rats overexpressing α-syn (p = 0.05, Fig. 6F ). In addition, we observed a positive correlation between relative TH+ fiber density in the ipsilateral vs. contralateral striatum and the Fig. 5 . Immunological gene expression profiling in the striatum and midbrain. qRT-PCR comparing Cd74, Cd86 and Arg-1 expression in midbrain and striatum of DA and DA.VRA4 animals overexpressing α-syn. Transcripts are related to housekeeping genes Gapdh and β-actin. DA.VRA4 presented a significant reduction of Cd74 (H) and Arg-1 (L) expression in the ipsilateral midbrain compared to DA animals. Data shown are normalized to DA contralateral side (n = 8 per group), mean fold change (ΔΔCT) ± SEM. Two-tailed t-tests were performed * p b 0.05. number of TH+ nigral neurons ( Fig. 6G ; r 2 = 0.4203, p b 0.01). These results suggest that the DA.VRA4 rats exhibit a higher susceptibility to α-syn induced neurodegeneration, and this differential susceptibility is first obvious at the axonal level.
DA.VRA4 rats display increased motor deficits induced by α-synoverexpression
To address whether expression levels of Mhc2ta and MHCII have functional consequences on the dopaminergic neurodegeneration induced by α-syn-overexpression we addressed forelimb akinesia using the stepping and cylinder test at 3, 8, and 12 weeks after rAAV-α-syn delivery (Fig. 7) . Overall, DA.VRA4 animals used the contralateral forepaw less on the adjusting steps test at all time points. The difference to DA was significantly different at 8 and 12 weeks post-surgery (Fig. 7A p b 0.05) . In the cylinder test, no significant differences were observed across strains at any of the time points (Fig. 7B) .
Relationships between antigen presenting cells and dopaminergic degeneration
In order to study correlations between antigen-presenting microglia, dopaminergic degeneration and motor deficits we performed linear regression. Interestingly, in the striatum the number of MHCII + cells were negatively correlated with TH + fiber staining intensity (r 2 = 0.33, p = 0.018, Fig. 8 A, B, E) . In the SN, the number of MHCII+ cells did not correlate with the number of TH+ cells when the two strains were combined (r 2 = 0.046, p = 0.23). However, strong correlations were observed in opposite directions within the two strains, with a positive correlation in DA rats (r 2 = 0.53, p = 0.019, Fig. 8C , D, F) and This data indicates that microglia in the SN exert different effects on the degeneration of nigral dopaminergic neurons upon overexpression of α-syn in the DA and DA.VRA4 strains.
Discussion
Despite the increasing evidence on expression of MHCII molecules being a key factor in the pathology and etiology of PD, this is the first study addressing the impact of natural genetic variants of the major regulator of MHCII expression (Mhc2ta) in an in vivo PD model. The data presented here indicates that in the rat α-syn overexpression PD model, Mhc2ta regulates key pathological features of PD including the number of local antigen-presenting cells, microglial phenotype, loss of dopaminergic fibers and behavioral impairment. Common allelic variant as the ones in our congenic rats are also present in humans, where similar polymorphisms in the orthologous gene (MHC2TA) are associated with a lower expression of MHC2TA and MHCII and with susceptibility to develop common complex diseases with inflammatory components (Lidman et al., 2003; Swanberg et al., 2005) . Taken together, this motivates future clinical studies of MHC2TA in relation to PD risk and progression.
It has been previously shown that the overexpression of α-syn induces an increase in MHCII expression (Harms et al., 2013; Kim et al., 2013; Sanchez-Guajardo et al., 2010) and in the absence of MHCII there is no microglial activation (Harms et al., 2013) . The rat VRA4 locus, which comprises naturally occurring alternative alleles of the Mhc2ta gene, regulates quantitatively the expression of MHCII in the CNS (Lidman et al., 2003; Swanberg et al., 2005) . Compared to parental DA rats, DA.VRA4 congenic rats carrying PVG alleles in the VRA4 locus express lower levels of MHCII in response to peripheral nerve injury and display a higher susceptibility to experimental autoimmune encephalomyelitis (Harnesk et al., 2008) and traumatic brain injury (Al Nimer et al., 2011) In concordance with these results, we here report a decreased α-syn-induced upregulation of Mhc2ta and MHCII transcripts in the striatum and midbrain of DA.VRA4 compared to DA rats. The lower expression of both Mhc2ta and MHCII genes in DA.VRA4 congenic rats relate to a lower transcriptional activity at the Mhc2ta gene (Lidman et al., 2003; Swanberg et al., 2005) . It is important to note that although Mhc2ta and MHCII genes have a lower transcriptional activity in DA.VRA4 rats compared to DA, we here demonstrate that DA.VRA4 rats display an increase in the number of MHCII+ cells, and a more reactive microglial activation profile. A lower MHCII surface receptor expression could potentially impact the activation state of microglia and macrophages and promote the recruitment of more antigen-presenting cells in order to mount a prompt inflammatory response against α-syn.
Based on stereological cell counts, we see similar numbers of CD11b + cells in the DA and DA.VRA4 strains, with only a moderate increase in the ipsilateral striatum after GFP/α-syn overexpression. In a previous study of rAAV6-α-syn overexpression in rodents, an increase in the percentage of CD11b+ cells was observed at 4 weeks post-injection, but returned to control levels after 8-15 weeks (Sanchez-Guajardo et al., 2010) . We thus cannot exclude strain differences in the amount of Cd11b+ cells at earlier time points.
A relation between α-syn pathology and microglia activation has been shown previously in humans and also in animal models (Sanchez-Guajardo et al., 2013) . Furthermore α-syn neuronal deposition in PD brains has been correlated to the presence of MHCII+ cells in the vicinity (Croisier et al., 2005) . To characterize the microglial response, we determined the number of MHCII+ cells and also analyzed the microglial activation profile based on morphological characteristics. We observed an increase in the number of striatal MHCII+ cells in DA and, even more increased, in DA.VRA4 rats overexpressing α-syn but not GFP. This suggests the increase in MHCII + cells to be a response specific to α-syn in the striatum., In the midbrain, however, the increase in the number of MHCII+ cells seems associated to the rAAV6 injection per se, or to the expression of a foreign protein, since an increase in MHCII + cells was observed in both GFP and α-syn overexpressing rats. This could be due to the SN being the site of injection, leading to high concentration of rAAV particles and tissue responses to the intraparenchymal injection.
It is well known that the activation of microglia is a finely regulated process, which depends on the nature of the stimulus and the prior state of the cell (Gomez-Nicola and Perry, 2015) . As morphologically and functionally dynamic cells, microglia are able to adopt diverse morphologies depending on their functional states. Various morphologies of microglia have been identified in the human brain, and progressive changes in microglial morphology occur in patients with Alzheimer's disease (Walker and Lue, 2015) . We categorized four different types of microglia (Types A-D) based on morphological characteristics and found that α-syn overexpression induced a shift towards more activated (Types B-D) microglia. DA.VRA4 rats presented the most polarized microglial profile, with an overrepresentation of bushy (Type C) and a drastic decrease of resting (Type A) microglia in the ipsilateral striatum and SN. The fact that DA.VRA4 animals present an increased percentage of activated microglia in these two regions supports the idea that Mhc2ta, directly or indirectly, regulates the activation state of microglia. Since DA.VRA4 rats also display an increased loss of dopaminergic fibers in the striatum and an enhanced behavioral impairment, the increase in activated microglia is associated with enhanced α-syn induced pathology.
As a complement to microglial cell counts and categorization, we performed gene expression analysis for markers of antigen-presentation capacity (CD74) as well as pro-inflammatory (CD86) and anti-inflammatory (Arg1) transcripts. CD74 is a transmembrane protein that assists and maintains the assembly of MHCII complexes in the endoplasmic reticulum until loaded with peptide in endosomes, and facilitates MHCII export from the ER in vesicles (Vyas et al., 2008) . It has also been showed that the cytokine macrophage migration inhibitory factor (MIF) is a natural ligand for CD74 and initiates a signaling cascade (Leng et al., 2003; Popp et al., 2009 ). We identified a significantly lower expression of CD74 in the SN of DA.VRA4 compared to DA, which may thus both reduce the antigen presentation capacity and modify intracellular signaling in DA.VRA4 microglia. We observed no differences in expression levels of the proinflammatory marker CD86 between DA and DA.VRA4 rats. We did, however, find a significantly reduced expression of Arg1, a well-studied anti-inflammatory marker that can contribute to wound healing and matrix deposition (Munder, 2009) , in the midbrain of DA.VRA4 rats. Arg1 converts arginine to polyamines, proline, and ornithines and thus competes with the substrate for inducible nitric oxide synthase to produce nitric oxide (NO). The lower Arg1 midbrain levels in DA-VRA4 could thus contribute to elevated NO production with neurotoxic effects, which is in line with the observed increase in neurogeneration and motor deficits in DA.VRA4 rats. Indeed, inflammatory-related nitration of α-syn has been previously correlated to dopaminergic neurodegeneration (Gao et al., 2008) .
The overexpression of α-syn has been shown to induce behavioral deficits of different degree depending on the level of dopaminergic neurodegeneration achieved (Decressac et al., 2012; Kirik et al., 2002) . In the present study, DA.VRA4 rats with α-syn overexpression displayed paw use asymmetry typical for a lesion of the nigrostriatal pathway, although they did not present any detectable loss of dopaminergic neurons in the SNpc. DA.VRA4 rats did, however, display a significant reduction in the ipsilateral striatal TH+ fiber density after α-syn overexpression, and this was significantly enhanced compared to DA rats. The impact of striatal TH + fiber loss on performance in behavioral tests without presenting a large cell loss, is supported by previous findings. Primates overexpressing wild-type α-syn showed motor impairments related to striatal axonal loss in the absence of cell death in SNpc (Eslamboli et al., 2007) . Furthermore α-syn induced changes of dopamine release and reuptake patterns can be detected before any sign of cell loss (Lundblad et al., 2012) . The correlation we observed between TH+ fiber density in the striatum and the number of remaining TH+ neurons in the SNpc supports the idea that in this model, motor deficits and striatal pathology are earlier characteristics than cell loss in the SNpc. The rather mild pathology observed in our model was thus enough to elicit striatal pathology and motor deficits in DA.VRA4 rats expressing lower levels of Mhc2ta, but not in DA rats.
There is abundant evidence that inflammation and immune system activation are contributors in the PD neurodegenerative process (Blandini, 2013; Croisier et al., 2005; McGeer et al., 1988; Ouchi et al., 2009 ). According to the notion that a complete lack of MHCII is neuroprotective in an α-syn overexpression mouse model (Harms et al., 2013) , the DA.VRA4 rat strain, which expresses lower Mhc2ta and MHCII levels, might be anticipated to be protected from detrimental effects of α-syn. On the contrary, we found the DA.VRA4 strain to be more susceptible to dopaminergic pathology, with higher numbers of MHCII+ cells, a higher proportion of activated microglia (with possibly a higher oxidative but lower antigen presentation capacity) and, importantly, increased loss of striatal TH + fibers and enhanced behavioral impairment. The reason why lower Mhc2ta and MHCII transcriptional activity in DA.VRA4 rats is associated with enhanced α-syn induced pathology could be due to a failure of microglial cells to efficiently signal to T-cells. T-cell interaction with MHCII will determine the immune response, for example regulatory T-cells (Tregs) interact with MHCII and modulate the antigen-presenting cell (Liang et al., 2008) . This may be of great importance since the adaptive immune system and Tcells have been linked to PD-like neurodegeneration (Olson and Gendelman, 2016; Romero-Ramos et al., 2014) , and might influence neuronal survival, since Tregs have been shown to be neuroprotective (Reynolds et al., 2007; Reynolds et al., 2010) . In DA rats, there was a positive correlation between nigral MHCII + and TH + cell counts, while the opposite was seen in DA.VRA4 where MHCII+ cells were negatively correlated to TH + cells. This indicates that the antigen-presenting capacity, combined with the microglial activation state and profile, determine the effect of microglia on dopaminergic neurons' susceptibility to α-syn overexpression.
Our data confirms the central role of MHCII in α-syn induced immune responses, and identifies Mhc2ta as a modulator of microglial activation, with consequences for dopaminergic pathology.
Concluding remarks
Inflammation is an important feature of PD, however the nature of the impact of inflammation on the pathophysiology of PD is poorly understood. This study emphasizes the complexity of inflammation in neurodegenerative disorders, and highlights the importance of combining quantitative and qualitative measures of microglia. In conclusion, we found that natural allelic differences in the Mhc2ta gene regulating MHCII expression levels impact microglial phenotype, antigen presentation capacity and dopaminergic pathology after overexpression of α-syn. These are key phenotypes for PD and should be considered in the search for disease-ameliorating therapies.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.nbd.2017.07.016.
